Sanjeev A Vasudevan Selected Research

Sanjeev A Vasudevan Research Topics

Disease

51	Neoplasms (Cancer) 06/2024 - 01/2007
17	Neuroblastoma 03/2023 - 01/2007
10	Hepatoblastoma 02/2024 - 10/2014
7	Liver Neoplasms (Liver Cancer) 06/2024 - 10/2015
6	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2007
3	Rhabdomyosarcoma 11/2019 - 01/2018
2	Circulating Neoplastic Cells 06/2024 - 07/2023
2	Margins of Excision 04/2024 - 11/2019
2	Carcinogenesis 10/2021 - 11/2017
2	Liver Diseases (Liver Disease) 01/2019 - 03/2015
1	Rupture 04/2024
1	Residual Neoplasm 04/2024
1	Hepatocellular Carcinoma (Hepatoma) 10/2023
1	Hemangiosarcoma (Angiosarcoma) 04/2022
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Vomiting 01/2021
1	Pain (Aches) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Desmoplastic Small Round Cell Tumor 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Peritonitis 01/2021
1	Postoperative Pain 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 10/2019
1	Islet Cell Adenoma (Islet Cell Tumors) 10/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Tuberous Sclerosis (Bourneville's Disease) 01/2017

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2007
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 10/2013
5	Indocyanine Green (Cardio-Green)FDA LinkGeneric 06/2024 - 01/2017
5	Phosphotransferases (Kinase)IBA 10/2019 - 03/2005
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2024 - 10/2014
4	RNA (Ribonucleic Acid)IBA 01/2024 - 08/2009
3	GlypicansIBA 06/2024 - 01/2019
3	RG7388IBA 03/2023 - 08/2017
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2007
3	tyrosine receptor (receptor, tyrosine)IBA 11/2017 - 03/2005
2	DAPIIBA 06/2024 - 07/2023
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2023
2	temsirolimus FDA Link 03/2023 - 11/2017
2	3-Iodobenzylguanidine (Iobenguane)IBA 08/2022 - 10/2016
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 10/2013
2	ElementsIBA 01/2016 - 10/2015
1	Vincristine (Oncovin)FDA LinkGeneric 01/2024
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2024
1	PanobinostatIBA 01/2024
1	Circulating Tumor DNAIBA 12/2023
1	IodineIBA 09/2023
1	MicroRNAs (MicroRNA)IBA 03/2023
1	CatecholaminesIBA 08/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	PolyaminesIBA 10/2021
1	ChromatinIBA 10/2021
1	Chromatin Assembly Factor-1IBA 10/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	MMEIBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	Narcotics (Narcotic Analgesics)IBA 01/2021
1	SR 1078IBA 01/2021
1	quintozene (PCNB)IBA 01/2020
1	agerafenibIBA 10/2019
1	Deubiquitinating EnzymesIBA 01/2019
1	Ubiquitin-Specific ProteasesIBA 01/2019
1	Orphan Nuclear ReceptorsIBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	regorafenibIBA 11/2017
1	EWS-FLI fusion proteinIBA 11/2017
1	YK 4-279IBA 11/2017
1	Caspase 3 (Caspase-3)IBA 11/2017
1	RNA Helicases (RNA Helicase)IBA 11/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2017
1	SuspensionsIBA 11/2017
1	Drug CombinationsIBA 11/2017
1	venetoclaxIBA 08/2017
1	Indicators and Reagents (Reagents)IBA 06/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	AfatinibIBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	bosutinibIBA 01/2017
1	trans-sodium crocetinate (crocetin)IBA 01/2017

Therapy/Procedure

20	Therapeutics 06/2024 - 01/2007
15	Drug Therapy (Chemotherapy) 04/2024 - 06/2012
4	Liver Transplantation 10/2023 - 01/2016
3	Radiotherapy 04/2024 - 02/2018
3	Hepatectomy 08/2022 - 10/2015
3	Metastasectomy 04/2022 - 04/2016
3	Length of Stay 01/2021 - 06/2012
2	Neoadjuvant Therapy 04/2024 - 01/2020
2	Pancreaticoduodenectomy 04/2022 - 01/2020
2	Thoracotomy 04/2022 - 01/2021
2	Combined Modality Therapy 11/2019 - 10/2019
2	Aftercare (After-Treatment) 11/2017 - 02/2013
2	Thyroidectomy 01/2017 - 06/2015
1	Precision Medicine 12/2023
1	Pneumonectomy (Lung Volume Reduction) 12/2021
1	Catheters 01/2021
1	Urinary Catheters 01/2021
1	Cytoreduction Surgical Procedures 01/2021
1	Hyperthermic Intraperitoneal Chemotherapy 01/2021